CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Cash flows used in operating activities:
Net loss	$ (32,097)	$ (51,078)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	169	185
Amortization of intangibles	11,182	36,637
Amortization of deferred financing costs	1,910	1,482
Accretion expense	2,468	2,702
PIK Interest	972	0
Stock compensation expense	885	1,404
Fair market value change in contingent consideration	143	(540)
Fair market value change in derivative liability	(21)	84
Gain on sale of assets	(446)	0
(Increase) decrease in operating assets:
Accounts receivable	10,042	5,483
Income tax receivable	22	962
Inventory	338	(707)
Prepaid expenses and other assets	2,532	851
Increase (decrease) in operating liabilities:
Accounts payable and accrued expenses	(1,739)	892
Accrued allowances	(2,289)	(5,222)
Interest payable	(458)	(595)
Other liabilities	(1,689)	(1,717)
Net cash used in operating activities	(8,076)	(9,177)
Cash flows from investing activities:
Proceeds from sale of non-core assets	446	0
Purchase of software and equipment	(98)	(3)
Net cash provided by (used in) investing activities	348	(3)
Cash flows from financing activities:
Payments on Treximet Secured Notes	(5,373)	(12,812)
Payment on financing costs	(221)	0
Payments on mortgages and capital leases	(24)	(42)
Proceeds from issuance of common stock, net of tax and costs	453	0
Shares withheld for the payment of taxes	(2)	0
Net cash used in financing activities	(5,167)	(12,854)
Net decrease in cash and cash equivalents	(12,895)	(22,034)
Cash and cash equivalents, beginning of period	32,820	36,375
Cash and cash equivalents, end of period	$ 19,925	$ 14,341